AU5569500A - Cholesterol biosynthesis inhibitors containing as the active ingredient aromaticcompounds bearing cyclic amino groups - Google Patents

Cholesterol biosynthesis inhibitors containing as the active ingredient aromaticcompounds bearing cyclic amino groups

Info

Publication number
AU5569500A
AU5569500A AU55695/00A AU5569500A AU5569500A AU 5569500 A AU5569500 A AU 5569500A AU 55695/00 A AU55695/00 A AU 55695/00A AU 5569500 A AU5569500 A AU 5569500A AU 5569500 A AU5569500 A AU 5569500A
Authority
AU
Australia
Prior art keywords
aromaticcompounds
active ingredient
amino groups
cyclic amino
biosynthesis inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55695/00A
Inventor
Yoshitaka Hosaka
Hidemitsu Nishida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of AU5569500A publication Critical patent/AU5569500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU55695/00A 1999-06-25 2000-06-26 Cholesterol biosynthesis inhibitors containing as the active ingredient aromaticcompounds bearing cyclic amino groups Abandoned AU5569500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18087999 1999-06-25
JP11/180879 1999-06-25
PCT/JP2000/004183 WO2001000616A1 (en) 1999-06-25 2000-06-26 Cholesterol biosynthesis inhibitors containing as the active ingredient aromatic compounds bearing cyclic amino groups

Publications (1)

Publication Number Publication Date
AU5569500A true AU5569500A (en) 2001-01-31

Family

ID=16090943

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55695/00A Abandoned AU5569500A (en) 1999-06-25 2000-06-26 Cholesterol biosynthesis inhibitors containing as the active ingredient aromaticcompounds bearing cyclic amino groups

Country Status (2)

Country Link
AU (1) AU5569500A (en)
WO (1) WO2001000616A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040063716A1 (en) * 2000-12-28 2004-04-01 Hidemitsu Nishida Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds
WO2004007444A2 (en) 2002-07-11 2004-01-22 Vicuron Pharmaceuticals, Inc. N-hydroxyamide derivatives possessing antibacterial activity
KR101120414B1 (en) 2003-04-24 2012-04-12 인사이트 코포레이션 Aza spiro alkane derivatives as inhibitors of metalloproteases
EP2477981A1 (en) * 2009-09-14 2012-07-25 Recordati Ireland Limited Heterocyclic mglu5 antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715892D0 (en) * 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
WO1999033805A1 (en) * 1997-12-26 1999-07-08 Mochida Pharmaceutical Co., Ltd. Aromatic compounds having cyclic amino or salts thereof
CN1290254A (en) * 1998-02-05 2001-04-04 武田药品工业株式会社 Sulfonamide derivatives process for producing the same and utilization thereof

Also Published As

Publication number Publication date
WO2001000616A1 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
AU4215800A (en) Dynamic server organization
AU4996300A (en) Method of electroporation-enhanced delivery of active agents
AU7490200A (en) New and improved formulation for paclitaxel
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
AU2001260455A1 (en) Cyclic amino acid derivatives useful as pharmaceutical agents
AU7962200A (en) Novel indole derivatives and drugs containing the same as the active ingredient
AU5270499A (en) Formulations having probiotically active microorganisms
HK1049966A1 (en) Dispersion formulations containing lipase inhibitors.
AU5920999A (en) Pesticidal compositions containing essential oils with enzyme inhibitors
AU4328800A (en) Pharmaceutical formulation
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
AU2001288114A1 (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
AU6309698A (en) Drugs containing aminopyridine derivatives as the active ingredient
AU2186501A (en) Dynamic deviation
AU2001232238A1 (en) Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
AU5213300A (en) 2-nh-pyridones and pyrimidones as mrs inhibitors
AU3078000A (en) Heterocyclic compounds and antitumor agents containing the same as the active ingredient
AU1043201A (en) Cyclosporin formulation
AU5460800A (en) Pharmaceutical transdermal compositions
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU2792700A (en) Pharmaceutical composition containing cyclosporin
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
AU2003227186A1 (en) Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase